Purchase Order 75N94022P00285
Award Date
3/30/22
Potential Completion Date
10/27/24
Potential Value
$12K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Pine Pharmaceuticals LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
This is a $15,000 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the provision of non-severable task order 1 for metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an FDA-registered 503B...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $15,400 firm fixed price purchase order to Pine Pharmaceuticals LLC. The contract is for the delivery of 6,6 D2Glucose intravenous stable isotopes to support metabolic research studies being conducted by NIDDK in Tonawanda, New York. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in high-quality pharmaceutical compounds and repackaged products, with...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals, LLC, a for-profit limited liability company. The contract has a potential value of $135,442.20 and a completion date of September 25, 2019. There is no set-aside designation mentioned. Based on the information provided, Pine Pharmaceuticals has a history...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $39,000 firm-fixed-price purchase order to Cambridge Isotope Laboratories, Inc. (CIL) for the delivery of deuterium oxide, D-glucose, glycerol, and other labeled compounds in support of biomedical research programs. CIL, a manufacturer of stable isotopes and isotopically labeled compounds, has provided similar labeled materials to NIH institutes like the...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency of the U.S. government, to Polyorg, Inc., a for-profit manufacturer of specialized chemicals. The $7,250 contract is for the procurement of chemicals to support NICHD's biomedical research, with a performance period ending on September 30, 2017. The contract does not have a set-aside designation. Based on Polyorg's prior federal contract history,...
This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation. Polypeptide Labs is a specialized manufacturer of peptides and related compounds,...